A detailed history of Schroder Investment Management Group transactions in Uni Qure N.V. stock. As of the latest transaction made, Schroder Investment Management Group holds 1,740,354 shares of QURE stock, worth $11.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,740,354
Previous 1,241,500 40.18%
Holding current value
$11.2 Million
Previous $6.46 Million 20.77%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.39 - $5.43 $2.19 Million - $2.71 Million
498,854 Added 40.18%
1,740,354 $7.8 Million
Q4 2023

Feb 13, 2024

BUY
$5.63 - $8.27 $6.99 Million - $10.3 Million
1,241,500 New
1,241,500 $8.4 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.